Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine infusion for sedation in upper limb surgery with nerve blocks
IRCT20170516033992N17Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine, sponsored by Urmia University of Medical Sciences. Primary endpoint: Sedation quality. Started Oct 2025; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on IRCT20170516033992N17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170516033992N17.